Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

WuXi Biologics (Cayman) Inc. WXXWY

Full chart Compare
Set alert

Price alert · WXXWY

All alert types
10.91 USD -0.37 (-3.28%)

Nov 3, 2026, 3:50 PM EST

10.91 Day range 11.13
7.30 52-week range 14.80
YTD
+36.38%
1 year
+20.02%

Financial health

Altman Z-Score

9.54 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 1
  • Return on Equity 4
  • Return on Assets 4
  • Debt / Equity 4
  • P/E 2
  • P/B 3

Valuation

P/E 23.5×
FY 2016: 98.7×FY 2017: 52.3×FY 2018: 29.9×FY 2019: 36.2×FY 2020: 200×FY 2021: 91.9×FY 2022: 49.0×FY 2023: 32.2×FY 2024: 20.7×FY 2025: 23.5×
FY 2016 5y median 32.2× FY 2025
P/S 5.3×
FY 2016: 14.1×FY 2017: 8.7×FY 2018: 7.4×FY 2019: 9.8×FY 2020: 64.4×FY 2021: 31.8×FY 2022: 14.9×FY 2023: 6.5×FY 2024: 3.7×FY 2025: 5.3×
FY 2016 5y median 6.5× FY 2025
P/B 2.4×
FY 2016: 51.5×FY 2017: 3.5×FY 2018: 2.4×FY 2019: 3.1×FY 2020: 17.6×FY 2021: 10.1×FY 2022: 6.5×FY 2023: 2.7×FY 2024: 1.6×FY 2025: 2.4×
FY 2016 5y median 2.7× FY 2025
P/FCF 40.3×
FY 2016: -40.2×FY 2017: -45.5×FY 2018: -32.5×FY 2019: -19.5×FY 2020: -87.2×FY 2021: -106×FY 2022: -696×FY 2023: 252×FY 2024: 53.4×FY 2025: 40.3×
FY 2016 5y median 40.3× FY 2025
EV/EBITDA 13.0×
FY 2016: 46.7×FY 2017: 27.3×FY 2018: 22.1×FY 2019: 30.0×FY 2020: 198×FY 2021: 88.4×FY 2022: 43.8×FY 2023: 19.1×FY 2024: 10.2×FY 2025: 13.0×
FY 2016 5y median 19.1× FY 2025
EV/Sales 5.0×
FY 2016: 15.1×FY 2017: 8.4×FY 2018: 5.8×FY 2019: 8.8×FY 2020: 63.7×FY 2021: 31.4×FY 2022: 14.8×FY 2023: 6.2×FY 2024: 3.5×FY 2025: 5.0×
FY 2016 5y median 6.2× FY 2025
FCF Yield 2.5%
FY 2016: -2.5%FY 2017: -2.2%FY 2018: -3.1%FY 2019: -5.1%FY 2020: -1.1%FY 2021: -0.9%FY 2022: -0.1%FY 2023: 0.4%FY 2024: 1.9%FY 2025: 2.5%
FY 2016 5y median 0.4% FY 2025

Profitability

Gross Margin 46.0%
FY 2016: 39.3%FY 2017: 40.8%FY 2018: 40.2%FY 2019: 41.6%FY 2020: 45.1%FY 2021: 46.9%FY 2022: 44.0%FY 2023: 40.1%FY 2024: 41.0%FY 2025: 46.0%
FY 2016 5y median 44.0% FY 2025
Operating Margin 30.5%
FY 2016: 20.4%FY 2017: 25.4%FY 2018: 20.6%FY 2019: 23.8%FY 2020: 26.8%FY 2021: 31.0%FY 2022: 28.5%FY 2023: 26.1%FY 2024: 26.6%FY 2025: 30.5%
FY 2016 5y median 28.5% FY 2025
Net Margin 22.5%
FY 2016: 14.3%FY 2017: 15.6%FY 2018: 24.9%FY 2019: 25.4%FY 2020: 30.1%FY 2021: 32.9%FY 2022: 29.0%FY 2023: 20.0%FY 2024: 18.0%FY 2025: 22.5%
FY 2016 5y median 22.5% FY 2025
ROE 10.1%
FY 2016: 52.2%FY 2017: 6.3%FY 2018: 7.9%FY 2019: 7.9%FY 2020: 8.2%FY 2021: 10.5%FY 2022: 12.6%FY 2023: 8.4%FY 2024: 8.0%FY 2025: 10.1%
FY 2016 5y median 10.1% FY 2025
ROIC 9.0%
FY 2016: 11.4%FY 2017: 8.5%FY 2018: 5.7%FY 2019: 5.6%FY 2020: 5.2%FY 2021: 7.5%FY 2022: 8.9%FY 2023: 7.7%FY 2024: 8.0%FY 2025: 9.0%
FY 2016 5y median 8.0% FY 2025
ROA 7.5%
FY 2016: 7.1%FY 2017: 5.2%FY 2018: 6.7%FY 2019: 5.8%FY 2020: 5.8%FY 2021: 7.7%FY 2022: 8.9%FY 2023: 6.0%FY 2024: 5.9%FY 2025: 7.5%
FY 2016 5y median 7.5% FY 2025

Growth (YoY)

Revenue 13.5%
FY 2016: 77.6%FY 2017: 63.7%FY 2018: 56.6%FY 2019: 57.2%FY 2020: 40.9%FY 2021: 83.3%FY 2022: 48.4%FY 2023: 11.6%FY 2024: 9.6%FY 2025: 13.5%
FY 2016 FY 2025
Operating Income 30.0%
FY 2016: 223.9%FY 2017: 103.8%FY 2018: 27.2%FY 2019: 81.5%FY 2020: 58.5%FY 2021: 112.2%FY 2022: 36.4%FY 2023: 2.3%FY 2024: 11.8%FY 2025: 30.0%
FY 2016 FY 2025
EPS (diluted) 43.6%
FY 2016: 216.8%FY 2017: 76.6%FY 2018: 118.3%FY 2019: 56.3%FY 2020: 60.0%FY 2021: 92.5%FY 2022: 31.2%FY 2023: -23.8%FY 2024: 1.3%FY 2025: 43.6%
FY 2016 FY 2025
Free Cash Flow 117.1%
FY 2016: -52.7%FY 2017: 10.6%FY 2018: -86.6%FY 2019: -245.9%FY 2020: -106.9%FY 2021: 25.8%FY 2022: 89.4%FY 2023: 233.8%FY 2024: 194.5%FY 2025: 117.1%
FY 2016 FY 2025

Financial Health

Current Ratio 3.1×
FY 2016: 1.0×FY 2017: 3.8×FY 2018: 4.4×FY 2019: 3.4×FY 2020: 3.2×FY 2021: 2.4×FY 2022: 2.0×FY 2023: 2.8×FY 2024: 2.7×FY 2025: 3.1×
FY 2016 5y median 2.7× FY 2025
Quick Ratio 3.0×
FY 2016: 0.9×FY 2017: 3.4×FY 2018: 4.2×FY 2019: 3.2×FY 2020: 2.9×FY 2021: 2.2×FY 2022: 1.7×FY 2023: 2.5×FY 2024: 2.6×FY 2025: 3.0×
FY 2016 5y median 2.5× FY 2025
Debt / Equity 0.1×
FY 2016: 4.2×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.2×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.7×
FY 2016: 3.0×FY 2017: -1.0×FY 2018: -6.1×FY 2019: -3.4×FY 2020: -2.1×FY 2021: -1.3×FY 2022: -0.4×FY 2023: -0.9×FY 2024: -0.5×FY 2025: -0.7×
FY 2016 5y median -0.7× FY 2025
Interest Coverage 46.5×
FY 2016: 8.3×FY 2017: 11.5×FY 2018: 0.0×FY 2019: 48.4×FY 2020: 35.2×FY 2021: 81.3×FY 2022: 67.6×FY 2023: 28.1×FY 2024: 31.6×FY 2025: 46.5×
FY 2016 5y median 46.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31